Improved method for assessing iron stores in the bone marrow
- K S Phiri1,
- J C J Calis1,2,
- D Kachala1,
- E Borgstein3,
- J Waluza3,
- I Bates4,
- B Brabin4,
- M Boele van Hensbroek1,2,4
- 1Malawi–Liverpool–Wellcome Trust Clinical Research Programme, College of Medicine, Blantyre, Malawi
- 2Emma Children’s Hospital AMC, University of Amsterdam, Netherlands
- 3Department of Surgery, College of Medicine, Blantyre, Malawi
- 4Liverpool School of Tropical Medicine, Liverpool, UK
- Dr K Phiri, Malawi–Liverpool–Wellcome Trust Clinical Research Programme, PO Box 30096, Blantyre 3, Malawi; kamijaphiri{at}gmail.com
- Accepted 19 February 2009
Abstract
Background: Bone marrow iron microscopy has been the “gold standard” method of assessing iron deficiency. However, the commonly used method of grading marrow iron remains highly subjective.
Aim: To improve the bone marrow grading method by developing a detailed protocol that assesses iron in fragments, in macrophages around fragments and in erythroblasts.
Methods: A descriptive study of marrow aspirates of 303 children (aged 6–60 months) with severe anaemia and 22 controls (children undergoing elective surgery) was conducted at hospitals in southern Malawi (2002–04).
Results: Using an intensive marrow iron grading method, 22% and 39% of cases and controls had deficient iron stores, and 40% and 46% had functional iron deficiency, respectively. Further evaluation of the iron status classification by the intensive method showed that functional iron deficiency was associated with significantly increased C-reactive protein concentrations (126.7 (85.6) mg/l), and iron stores deficiency with significantly increased soluble transferrin receptor concentrations (21.7 (12.5) μg/ml).
Conclusions: Iron assessment can be greatly improved by a more intense marrow examination. This provides a useful iron status classification which is of particular importance in areas where there is a high rate of inflammatory conditions.
Footnotes
-
Competing interests: None.
-
Funding: The study was supported by the Wellcome Trust, Gates Malaria Partnership, and Numico and Ter Meulen Foundation.
-
Ethics approval: Ethics approval was obtained.








